1. Introduction
===============

Natural colored pigments from plant products have drawn great attention worldwide. These pigments display various colors and are made up of different phytochemicals commonly ound in the food matrix such as orange (β-carotene), yellowish-green (lutein), green (chlorophyll), and blue-purple (anthocyanin) \[[@B1-molecules-15-00959]\]. Lycopene is the red colored pigment abundantly found in red colored fruits and vegetables such as tomato, papaya, pink grapefruit, pink guava and watermelon. This red colored pigment was first discovered in the tomato by Millardet in 1876 \[[@B2-molecules-15-00959]\]. It was later named lycopene by Schunck \[[@B2-molecules-15-00959]\].

Lycopene is a carotenoid hydrocarbon (also called carotene). The extended conjugated double bond system of these compounds is an important feature in the carotenoids responsible for their attractive colors because it forms the light absorbing chromophore \[[@B3-molecules-15-00959]\]. The existence of visible color in these compounds requires at least seven conjugated double bonds. The greater the number of conjugated double bonds, the higher a wavelength value for maximum absorption \[[@B4-molecules-15-00959]\] is observed.

Lycopene is one of the popular pigments highly accepted by food industry as a food additive and also for its health benefits \[[@B5-molecules-15-00959],[@B6-molecules-15-00959]\]. As a red colorant and antioxidant agent, the demand for lycopene is still increasing. According to \[[@B5-molecules-15-00959]\], total world consumption of lycopene was tripled to 15,000 tonnes in 2004 compared to 5000 tonnes in 1995. Thus, alternative sources for the production of natural lycopene are warranted. Previously, *in vitro* and *in vivo* studies exhibited that lycopene has a beneficial role in chronic diseases such as cardiovascular disease, atherosclerosis, cancer and neurodegenerative disorders. However, some studies reported contrasting outcomes. This review offers an overview of the properties of ycopene with recent evidence on its contributions in human health and also provides broad information on lycopene in food processing by-products.

The importance of natural food additives is given more attention due to an extensive use of the natural ingredients rather than synthetic compounds in food, cosmetics and pharmaceuticals. Meanwhile, the prices of raw materials are increasing and their availability is decreasing. Food processing by-products from orange \[[@B7-molecules-15-00959]\], mango \[[@B8-molecules-15-00959],[@B9-molecules-15-00959],[@B10-molecules-15-00959]\], guava \[[@B8-molecules-15-00959],[@B11-molecules-15-00959],[@B12-molecules-15-00959],[@B13-molecules-15-00959],[@B14-molecules-15-00959]\], pomegranate \[[@B15-molecules-15-00959],[@B16-molecules-15-00959]\], and also vegetables including tomato \[[@B17-molecules-15-00959],[@B18-molecules-15-00959],[@B19-molecules-15-00959],[@B20-molecules-15-00959]\], and carrot \[[@B21-molecules-15-00959]\] are potential sources of functional foods, and at the same time these by-products are natural sources for lycopene and may have preventive effects against numerous diseases.

2. Lycopene in Food and Its Properties
======================================

Lycopene is an unsaturated acyclic carotenoid with 11 linear conjugated and two non-conjugated double bonds. It is not the precursor for vitamin A, since it lacks the terminal β-ionic ring found in the basic structure of vitamin A. The red color of certain fruits and vegetables such as tomato, pink grapefruit, red grapes, watermelon and red guava is due to the presence of lycopene. Lycopene is reported as the most efficient singlet oxygen quencher in carotenoids group, whose quenching ability is mainly dependent on the number of conjugated double bonds, and to a lesser influenced by either the presence of cyclic or acyclic end groups \[[@B22-molecules-15-00959]\]. In addition, its chain structure with an extensive conjugated polyene system is important for its biological properties such as susceptibility to oxidative degradation \[[@B23-molecules-15-00959]\].

Lycopene occurs naturally as all *trans* form and its chain containing seven double bonds that can be isomerized to mono-*cis* or poly-*cis* due to the exposure to high temperatures, light, oxygen, acids, catalyst and metal ions \[[@B23-molecules-15-00959]\]. Lycopene is a lipophilic compound with hydrophobic characteristics due to its acyclic structure and 11 linear conjugated double bonds that make it more soluble in organic solvents such as chloroform, hexane, benzene, methylene chloride, acetone and petroleum ether \[[@B24-molecules-15-00959]\]. Physical properties and molecular structure of lycopene are shown in [Table 1](#molecules-15-00959-t001){ref-type="table"} and [Figure 1](#molecules-15-00959-f001){ref-type="fig"}, respectively.

molecules-15-00959-t001_Table 1

###### 

Physical properties of lycopene.

  ------------------------------------------ ---------------------------------------------------------------------------------------------
  Molecular formula                          C~40~H~56~
  Molecular weight                           536.85 Da
  Melting point                              172--175 ºC
  Crystal form                               Long red needles separate from a mixture of carbon disulfide and ethanol
  Powder form                                Dark reddish-brown
  Solubility                                 Soluble in chloroform, hexane, benzene, carbon disulfide, acetone, petroleum ether and oil;
  Insoluble in water, ethanol and methanol   
  Stability                                  Sensitive to light, oxygen, high temperature, acids, catalyst and metal ions
  ------------------------------------------ ---------------------------------------------------------------------------------------------

Source: Shi *et al.* \[[@B23-molecules-15-00959]\].

3. Lycopene Absorption, Transportation and Distribution in Human
================================================================

3.1. Absorption
---------------

As a fat soluble compound, lycopene has a similar absorption as dietary fat. In the stomach and duodenum, lycopene will separate from the food matrix and subsequently dissolve in the lipid phase \[[@B26-molecules-15-00959]\]. Prior to absorption, the lipid phase will form droplets, resulting from the reaction with bile salts and pancreatic lipases. Then, it enters the duodenum and appears as the multi-lamellar lipid vesicles \[[@B27-molecules-15-00959]\]. Finally, the lipid vesicles will absorb into small intestine via passive or diffusion process \[[@B26-molecules-15-00959]\]. Additionally, there are *in vitro* studies suggested that the intestinal absorption of lycopene was aided by the participation of a specific epithelial transporter \[[@B28-molecules-15-00959],[@B29-molecules-15-00959]\].

![Molecular structures of lycopene isomers.](molecules-15-00959-g001){#molecules-15-00959-f001}

The absorption of lycopene was reported to be lower compared to other carotenoids based on an *in vitro* study using the Caco-2 cell line \[[@B29-molecules-15-00959]\]. However, there are many factors that might affect the absorption of lycopene. The degree of lycopene release from the food matrix into the digestive tract will be lowered when the indigestible fraction increases \[[@B30-molecules-15-00959]\]. High fibers diets will reduce the uptake of lycopene and decrease lycopene adsorption whereby lycopene supplemented together with different dietary fibers has resulted in the reduction of plasma lycopene for more than 40% \[[@B31-molecules-15-00959]\]. The bioaccessibility of lycopene in the intestine has also discussed by Goñi *et al.* \[[@B30-molecules-15-00959]\] who showed that the release of lycopene was higher in the large intestine (57%) than the small intestine (40%), but the potential for lycopene to be absorbed in the large intestine is negligible. Furthermore, an *in vitro* study using Caco-2 cells showed that the uptake of *cis* lycopene was significantly greater than for all *trans* isomer \[[@B32-molecules-15-00959]\]. Thus, *cis* isomers have higher bioavailability than all *trans*-isomers.

The nature of the human body is believed to cause the isomerization of lycopene along the digestive tract. A study reported that 60% of *cis* lycopene isomers occurred in human plasma, even though the early consumption of the lycopene rich food that mostly consisted of all *trans* lycopene (\>90%) \[[@B33-molecules-15-00959]\]. An *in vivo* study also explained that the acidic condition in gastric milieu will enhance isomerization of the all *trans* lycopene to *cis* isomers \[[@B34-molecules-15-00959]\]. This mechanism will further improve the absorption of lycopene once the lycopene reaches the small intestine.

Food processing is one of the factors which can affect the bioavailability of lycopene, and thus increase absorption. The heating of tomato sauce purposely to induce isomerization of all *trans* lycopene to *cis* isomers could increase the bioavailability of lycopene \[[@B35-molecules-15-00959]\]. Furthermore, *in vitro* study showed sun dried tomatoes give the highest bioavailabiliy of lycopene as compared to fresh and canned tomatoes \[[@B36-molecules-15-00959]\]. Besides, ingestion of lycopene together with oil would also help in increasing its bioavailability \[[@B37-molecules-15-00959]\]. A human study shown that a combination of salad dressing and canola oil increased lycopene content in plasma chylomicrons as compared to fat free salad dressing \[[@B38-molecules-15-00959]\]. This is in agreement with the results of Fielding *et al.* \[[@B39-molecules-15-00959]\] showing that tomatoes cooked with olive oil greatly increase the lycopene level in human plasma as compared to the tomatoes cooked without olive oil. Moreover, bioavailability of lycopene was found to be impaired in elderly people \[[@B40-molecules-15-00959]\].

3.2. Transportation
-------------------

After the uptake by intestinal mucosa, lycopene will be parceled into triacylglycerol-rich chylomicrons and will be secreted into lymph transport system, and lastly transferred to the liver \[[@B24-molecules-15-00959]\]. Lycopene is prone to accumulate in the lipophilic compartments of membrane or lipoprotein \[[@B41-molecules-15-00959]\]. It is transported by plasma lipoproteins and the distribution depends on its chemical structure. As a hydrophobic compound, lycopene is found at the lipophilic part of lipoproteins which is the core of the lipoprotein \[[@B27-molecules-15-00959]\], while other polar carotenoids can be found at the surface of lipoproteins. Therefore, lycopene is mostly transported by low density lipoproteins, while other oxygenated carotenoids are transported by both low density and high density lipoprotein \[[@B27-molecules-15-00959]\]. In addition, *cis* isomers of lycopene were reported to have higher ability to be incorporated in lipoprotein and other protein compared to all *trans* isomer due to the shorter chain length \[[@B42-molecules-15-00959]\].

molecules-15-00959-t002_Table 2

###### 

Plasma lycopene levels in people from different countries.

  References                      Country                 Plasma lycopene levels (µmol/L)   
  ------------------------------- ----------------------- --------------------------------- ------------------
  \[[@B49-molecules-15-00959]\]   UK                      \-                                0.32 ± 0.12
  \[[@B50-molecules-15-00959]\]   USA                     0.82 ± 0.38                       0.76 ± 0.32
  \[[@B51-molecules-15-00959]\]   France                  0.66 (0.18-1.47)                  0.66 (0.31-2.06)
                                  Republic of Ireland     0.73 (0.09-2.12)                  0.57 (0.09-0.65)
                                  The Netherland          0.54 (0.08-1.72)                  0.53 (0.04-1.98)
                                  Spain                   0.53 (0.21-1.16)                  0.51 (0.07-1.72)
                                  Ireland                 0.30 ± 0.13                       0.25 ± 0.11
  \[[@B52-molecules-15-00959]\]   Italy (Varese/Turin)    1.03 ± 0.43                       0.90 ± 0.37
                                  Italy (Florence)        1.01 ± 0.37                       0.90 ± 0.36
                                  Italy (Ragusa/Naples)   1.29 ± 0.46                       1.32 ± 0.46
                                  Greece (Athens)         0.90 ± 0.38                       0.87 ± 0.47
                                  Spain (Granada)         0.69 ± 0.40                       0.69 ± 0.33
                                  Spain (Murcia)          0.66 ± 0.30                       0.74 ± 0.35
                                  Northern Spain          0.53 ± 0.31                       0.43 ± 0.29
                                  UK (vegetarians)        0.98 ± 0.45                       0.89 ± 0.44
                                  UK (Cambridge)          0.72 ± 0.30                       0.77 ± 0.38
                                  Germany (Potsdam)       0.60 ± 0.30                       0.69 ± 0.33
                                  Germany (Heidelberg)    0.62 ± 0.31                       0.54 ± 0.25
                                  The Netherlands         0.54 ± 0.33                       0.47 ± 0.26
                                  Denmark                 0.58 ± 0.34                       0.53 ± 0.29
                                  Sweden (Malmö)          0.46 ± 0.24                       0.52 ± 0.27
                                  Sweden (Umeå)           0.56 ±0.37                        0.44 ± 0.25
  \[[@B53-molecules-15-00959]\]   Japan                   0.11 (0.04-0.33)                  0.20 (0.08-0.52)
  \[[@B54-molecules-15-00959]\]   Thailand                0.46 ± 0.33                       0.74 ± 0.38

3.3. Distribution
-----------------

The distribution of lycopene in human organs and plasma has been reported by Erdman \[[@B43-molecules-15-00959]\], where higher concentrations of lycopene are found in the liver, adrenal and reproductive tissues (ten times higher than other tissues). The concentrations were within the range of 0.2--21.4 nmol/g tissue \[[@B44-molecules-15-00959]\]. Goralczk and Siler \[[@B44-molecules-15-00959]\] reported that lycopene concentration was the highest in human testes, followed by adrenal gland \> liver \> prostate \> breast \> pancreas \> skin \> colon \> ovary \> lung \> stomach \> kidney \> fat tissue \> cervix. A review by Rao and Argawal \[[@B6-molecules-15-00959]\] quoted that lycopene concentrations in human tissues are around 0.15--21.36 nmol/g tissue, but not detectable in brainstem tissue. On the other hand, a study on rats carried out by Zaripheh *et al.* \[[@B45-molecules-15-00959]\] showed that lycopene was highly distributed in the liver. Besides, high lycopene content was found in adipose tissue, the spleen and adrenal tissue. The excretion of lycopene through feces and urine was also reported \[[@B45-molecules-15-00959]\].

In human, total serum carotenoids is about 1--2 µM, with lycopene being one of the major carotenoids present in human serum \[[@B46-molecules-15-00959]\]. The level of plasma lycopene can vary among the people from different countries ([Table 2](#molecules-15-00959-t002){ref-type="table"}). Porrini *et al.* \[[@B47-molecules-15-00959]\] suggested the eating behavior of different individuals makes the lycopene level vary among people. Recently, a study reported that plasma lycopene level could be diverged among married, non-married and divorced subjects \[[@B48-molecules-15-00959]\].

The lycopene metabolite products were recently studied by Lindshield *et al.* \[[@B55-molecules-15-00959]\] and lycopene metabolites were formed by reacting with carotenoid monooxygenase (CMO) II. Study using post-mitochondrial fraction of rat mucosa with soy lipoxigenase reviewed that cleavage products and oxidation products will be formed from lycopene metabolism \[[@B56-molecules-15-00959]\]. These cleavage products were 3-keto-apo-13-lycopenone and 3,4-dehydro-5,6-dihydro-15,15-apo-lycopenal, while the oxidation products were 2-apo-5,8-lycopenal-furanoxide, lycopene-5,6,5',6'-diepoxide, lycopene-5,8-furanoxide isomer (I), lycopene-5,8-furanoxide isomer (II), and 3-keto-lycopene-5,8-furanoxide ([Figure 2](#molecules-15-00959-f002){ref-type="fig"}). An *in vitro* study using liposomal suspension showed that 8 carbonyl compounds namely 3, 7, 11-trimethyl-2, 4, 6, 10-dodecatetraen-1-al, 6, 10, 14-trimethyl-3, 5, 7, 9, 13 pentadecapentaen-2-one, acycloretinal, apo-14′-lycopenal, apo-12′-lycopenal, apo-10′-lycopenal, apo-8′-lycopenal, apo-6′-lycopenal and acycloretinoic acid were formed from lycopene oxidation \[[@B57-molecules-15-00959]\]. In rats, 2 cleavage products were detected in the liver, which are apo-8′-lycopenal and apo-12´-lycopenal. However, Hu *et al.* \[[@B58-molecules-15-00959]\] reported only apo-10′-lycopenal was found in ferret carotene-9\',10\'-monooxygenase catalyzed cleavage of carotenoids.

![Proposed structures of the metabolites detected.](molecules-15-00959-g002){#molecules-15-00959-f002}

4. Lycopene as Antioxidant and Its Mechanism of Function
========================================================

The reactivity of carotenoids, especially lycopene, in biological systems depends on their molecular and physical structure, location or site of action within the cells, ability to interact with other antioxidants, concentration and the partial pressure of oxygen \[[@B59-molecules-15-00959],[@B60-molecules-15-00959]\]. Biologically, lycopene tends to act as singlet oxygen (^1^O~2~) and peroxyl radical scavenger (LOO•) \[[@B41-molecules-15-00959]\]. Lycopene degradation may result in color loss when exposed to free radicals or oxidizing agents. This is due to the reaction with free radicals and causes interruption of the polyene chain, in which the conjugated double bond system may either be affected by cleavage or addition to one of the double bonds \[[@B26-molecules-15-00959]\].

The highly conjugated double bonds of lycopene play the most important role in energy transfer reactions \[[@B60-molecules-15-00959],[@B61-molecules-15-00959]\]. Lycopene has quenching ability towards singlet oxygen (^1^O~2~), based on the excited energy state, and is greatly related to the length of the conjugated double bond system \[[@B60-molecules-15-00959]\]. Among the carotenoids, lycopene is the most efficient singlet oxygen quencher \[[@B62-molecules-15-00959],[@B63-molecules-15-00959]\]. The physical quenching rate of lycopene was two times higher than β-carotene and 10 times higher than α-tocopherol \[[@B62-molecules-15-00959]\].

Basically, chain lipid autoxidation reactions can be interrupted by antioxidants such as phenols, vitamin E and flavonoids, which eliminate the lipid peroxyl radicals by donating the hydrogen atom to form lipid peroxide and a resonance-stabilized antioxidant radical \[[@B64-molecules-15-00959]\]. However, as a carotenoid compound, lycopene may scavenge the radicals by other ways. The mechanism of action for lycopene towards the reactive species can be predicted through three possible mechanisms: (1) adduct formation, (2) electron transfer to the radical and (3) allylic hydrogen abstraction \[[@B26-molecules-15-00959],[@B60-molecules-15-00959],[@B64-molecules-15-00959],[@B65-molecules-15-00959],[@B66-molecules-15-00959]\], and is also shown in [Figure 3](#molecules-15-00959-f003){ref-type="fig"}.

![Three Possible Reactions of Carotenoids with Radical Species (R^•^).](molecules-15-00959-g003){#molecules-15-00959-f003}

Adduct formation is the formation of resonance-stabilized carbon centered-peroxyl radicals where the free radical will attach to the polyene chain, the highly conjugated double bonds of lycopene, to form a lycopene-peroxyl radical adduct (ROO-lycopene^•^) \[[@B64-molecules-15-00959],[@B67-molecules-15-00959]\]. This reaction is described in (1) where the lipid peroxyl radical (ROO^•^) reacts with lycopene.

\(1\) Lycopene + ROO^•^ ![](molecules-15-00959-i001.jpg) ROO-lycopene^•^

Under high oxygen concentrations, the ROO-lycopene^•^may possibly react with O~2~ to form a new radical (reaction 2). This reaction was reported as reversible and related to the pro-oxidant effect which may occur in carotenoid compounds \[[@B66-molecules-15-00959]\].

\(2\) ROO-lycopene^•^ + O~2~ ![](molecules-15-00959-i002.jpg) ROO-lycopene-OO^•^

The pro-oxidant effect of the peroxyl radical-lycopene adduct (ROO-lycopene^•^) can be explained if this compound is further reacted with oxygen forming a new lycopene-peroxyl radical (ROO-lycopene-OO^•^) \[[@B68-molecules-15-00959]\]. This intermediate species (ROO-lycopene-OO^•^) will subsequently act as a pro-oxidant or initiator for lipid peroxidation by reacting with lipid (RH) (reaction 3) and forming another peroxyl radical (ROO^•^) with oxygen (O~2~) (reaction 4).

\(3\) ROO-lycopene-OO^•^+ RH ![](molecules-15-00959-i001.jpg) ROO-lycopene-OOH + R^•^

\(4\) R^•^+ O~2~ ![](molecules-15-00959-i001.jpg) ROO^•^

However, the peroxyl radical-lycopene adduct may also be terminated in the occurence of another peroxyl radical by forming the inactive end products (reaction 5) \[[@B68-molecules-15-00959]\].

\(5\) ROO-lycopene^•^ + ROO^•^![](molecules-15-00959-i001.jpg) inactive products

Lycopene is one of the carotenoids prone to oxidation \[[@B65-molecules-15-00959]\]. It is the best antioxidant based on electron transfer reactions \[[@B69-molecules-15-00959]\]. Electron transfer, is the reaction with formation of carotenoid radicals such as lycopene cation radical (lycopene^+•^), anion radical (lycopene^-•^) or alkyl radical (lycopene^•^). Nitrogen dioxide radical (NO~2~^•^) from smoking, an environmental pollutant and the powerful oxidant trichloromethylperoxyl (CCl~3~O~2~^•^) may convert lycopene into radical cations (reaction 6 and 7) \[[@B65-molecules-15-00959]\].

\(6\) NO~2~^•^+ Lycopene ![](molecules-15-00959-i001.jpg) NO~2~^-^+ Lycopene^+•^

\(7\) CCl~3~O~2~^•^+ Lycopene ![](molecules-15-00959-i001.jpg) \[CCl~3~O~2~- Lycopene\]^•^![](molecules-15-00959-i001.jpg) CCl~3~O~2~^-^+ Lycopene^+•^

In addition, the reaction between lycopene and superoxide radical (O~2~^-•^) through electron transfer can form the lycopene anion radical (reaction 8) \[[@B70-molecules-15-00959]\].

Lycopene + O~2~^-•^ ![](molecules-15-00959-i002.jpg) Lycopene ^-•^ + O~2~

However, hydrogen abstraction is the reaction of carotenoids as hydrogen donor to reduce the radical. The reaction is presented in reaction 9 \[[@B66-molecules-15-00959]\].

\(9\) Lycopene + ROO^•^![](molecules-15-00959-i001.jpg) Lycopene^•^+ ROOH

Again, the modes of action for antioxidants were depended on their position in the cell \[[@B60-molecules-15-00959]\]. Carotenes such as lycopene lie parallelly with the membrane surface \[[@B71-molecules-15-00959],[@B72-molecules-15-00959]\]. Thus, lycopene is expected to be a poor antioxidant due to its limited interaction with aqueous phase radicals in the lipid bilayer as compared to more polar carotenoids such as zeaxanthin \[[@B60-molecules-15-00959]\]. Besides, high concentration of lycopene in the membranes may cause aggregation that may affect the properties of membrane by leading to increase in membrane fluidity and permeability, and finally will result in pro-oxidant type effects \[[@B73-molecules-15-00959]\]. However, lycopene is still important in inhibiting lipid radicals at membranes as the first defense system of cells. Moreover, a combination of lycopene and other antioxidants is also important in scavenging of reactive species.

5. Interaction of Lycopene with Other Antioxidants
==================================================

In lipid bilayer of cellular membrane, lycopene is expected to be a poor antioxidant due to its lesser interaction with aqueous phase radicals. However, the role of lycopene as a lipid phase antioxidant should not be neglected. The combinations of lycopene and other antioxidants such as vitamin C, vitamin E and β-carotene has exhibited higher scavenging activity on 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical than their individual antioxidant activity \[[@B74-molecules-15-00959]\]. Besides, lycopene combined with other antioxidants also gave a better inhibiting effect towards diene hydroperoxides produced from linoleic methyl ester with 2,2\'-azobis (2,4-dimethylvaleronitrile) (AMVN) induced oxidation \[[@B75-molecules-15-00959]\]. Lycopene was also reported to help in repairing the vitamin E radical (reaction 10) and the products from this reaction radical cation will be repaired by vitamin C (reactions 11 and 12) \[[@B76-molecules-15-00959]\].

\(10\) Lycopene**+**TOH^+^**˙**![](molecules-15-00959-i001.jpg) TOH + Lycopene^+^**˙**

\(11\) Lycopene^+^**˙ +**ASCH~2~ ![](molecules-15-00959-i001.jpg) Lycopene + ASCH**˙ +**H^+^

\(12\) Lycopene^+^**˙ +**ASCH^-^ ![](molecules-15-00959-i001.jpg) Lycopene + ASCH**˙**^-^ **+**H^+^

Previously, lycopene was reported to react effectively with vitamin E radical in the lipophilic compartment \[[@B60-molecules-15-00959]\]. Inversely, their reaction with the hydrophilic vitamin C was expected to be less effective. Yeum *et al.* \[[@B77-molecules-15-00959]\] had suggested a model for the synergistic interactions among the antioxidants located in the hydrophilic and lipophilic compartments of plasma. Besides, there might be lycopene-carotenoid interaction in biological system (reaction 13). A study done using multilamellar liposomes showed that lycopene and lutein was the best combination toward AMVN-induced oxidation \[[@B78-molecules-15-00959]\]. Lycopene is the strongest reducing agent and able to reduce the radical cations of lutein and zeaxanthin, but not β-carotene \[[@B79-molecules-15-00959],[@B80-molecules-15-00959]\].

\(13\) Carotenoid^+^**˙ +**Lycopene ![](molecules-15-00959-i001.jpg) Carotenoid + Lycopene^+^**˙**

Different interpretations of reactions between lycopene with vitamin E and vitamin C is also reported \[[@B25-molecules-15-00959],[@B66-molecules-15-00959],[@B68-molecules-15-00959]\]. Lycopene is suggested to protect tocopherol through the electron transfer to form α-tocopheroxyl radical (α-TO**˙**)(reaction 14) \[[@B81-molecules-15-00959]\].

\(14\) α-TO**˙**+ Lycopene ![](molecules-15-00959-i001.jpg) α-TOH + Lycopene^+^**˙**

On the other hand, some researchers suggestied that α-tocopherol (α-TOH) could reduce lycopene^+^**˙**to regenerate the intact lycopene (reaction 15) \[[@B26-molecules-15-00959]\].

\(15\) α -TOH + Lycopene^+^**˙**![](molecules-15-00959-i001.jpg) α-TO**˙** + Lycopene

However, a different reaction of lycopene radical cation (lycopene^+^**˙**) and α-tocopherol (α-TOH) or δ-tocopheroxyl radical (δ-TO**˙)** was also reported \[[@B82-molecules-15-00959]\] as the following reactions (reactions 16 and 17).

\(16\) α -TOH + Lycopene^+^**˙**![](molecules-15-00959-i001.jpg) α-TO**˙**+ Lycopene

\(17\) δ-TO**˙** + Lycopene ![](molecules-15-00959-i001.jpg) δ-TOH + Lycopene^+^**˙**

In non-polar solvents, carotenoids will probably react with α-tocopherol radical cation (α-TOH^+^**˙**) rather than with α-tocopherol anion (α-TOH**^-^**) as given in the reaction 18 \[[@B26-molecules-15-00959]\]:

\(18\) α -TOH^+^**˙**+ Lycopene ![](molecules-15-00959-i001.jpg) α-TOH**^-^** + Lycopene^+^**˙**

However, the reaction between lycopene and ascorbic acid increase the decay rate of Lycopene^+^**˙**due to the following reaction (reaction 19) \[[@B26-molecules-15-00959],[@B66-molecules-15-00959],[@B83-molecules-15-00959]\]:

\(19\) Lycopene^+^**˙**+ AscH**^-^** ![](molecules-15-00959-i001.jpg) Lycopene + Asc**^-^˙**+ H^+^

Lycopene in combination with other antioxidants such as vitamins E and C, polyphenols and other carotenoids have wide potential for human health \[[@B60-molecules-15-00959],[@B84-molecules-15-00959]\]. Recent formulations of antioxidant mixtures in the development of nutritional products has been in favour for their health benefits \[[@B85-molecules-15-00959]\].

6. Preventive Effect of Lycopene toward Diseases
================================================

The effects of lycopene towards various diseases have been previously reviewed by many researchers. The protective effects of lycopene have been shown on oxidative stress, cardiovascular disease, hypertension, atherosclerosis, cancers, diabetes and others. However, there are still no conclusive results reported due to the fact studies on the role of lycopene against these diseases is still ongoing.

6.1. Oxidative stress
---------------------

Oxidative stress is one of the major risk factors of chronic diseases \[[@B86-molecules-15-00959]\]. Free radicals or oxidants are potential contributors leading to oxidative stress. *In vitro, ex vivo*, and *in vivo* studies have been carried out to demonstrate the effects of lycopene against oxidative stress. In this context, lipid, protein and DNA oxidation are closely related to oxidative stress.

Previous studies have reported lycopene-rich diet and lycopene supplementation provided protective effects against DNA damage in both normal and cancerous human cells \[[@B87-molecules-15-00959],[@B88-molecules-15-00959],[@B89-molecules-15-00959]\]. In animals, reduction of lipid peroxidation products (thiobarbituric acid reactive substances, TBARS) and DNA damage markers were found in monkey kidney fibroblast and rat hepatocytes supplemented with lycopene (20 pmol/106 cells and 1.86--18.62 μM, respectively) \[[@B90-molecules-15-00959],[@B91-molecules-15-00959]\]. Rats injected with lycopene (10 mg/kg/day, five days) also showed protective effect from iron-induced oxidative damage in prostate tissue and reduction of lipid peroxidation \[[@B92-molecules-15-00959]\].

Human plasma lycopene levels have shown an inverse association with oxidative DNA damage \[[@B93-molecules-15-00959]\]. Consumption of lycopene rich foods, juices or supplements has demonstrated protective effects against DNA damage in lymphocytes \[[@B47-molecules-15-00959],[@B94-molecules-15-00959],[@B95-molecules-15-00959]\]. Besides, a high protection of lymphocytes from oxidative damage due to singlet oxygen and nitrogen dioxide was found in human subjects with the higher intake of lycopene-rich tomato juice \[[@B96-molecules-15-00959]\]. Lycopene can protect human lymphoid cells from singlet oxygen by binding to the surface of the cells \[[@B97-molecules-15-00959]\], but although consumption of tomato products has contributed to protecting lymphocytes from DNA damage, for lipid oxidation, a decrease in malondialdehyde (MDA) level was not found \[[@B98-molecules-15-00959]\]. However, Riso *et al.* \[[@B99-molecules-15-00959]\] reported no significant differences in endogenous lymphocyte DNA damage and 8-iso-prostaglandin F2α between a tomato-based drink treated group and placebo.

A decrease of lipid and protein oxidation was also obtained in human consumed lycopene in the form of ketchup or oleoresin capsules \[[@B100-molecules-15-00959],[@B101-molecules-15-00959]\]. Besides, the LDL oxidation and urinary 8-iso-prostaglandin F2α was found to be lower after the consumption of tomato products (8 mg lycopene/day, three weeks) \[[@B102-molecules-15-00959]\]. Lycopene capsule supplementation (4 mg/day for six months) could substitute the hormone replacement therapy in postmenopausal women to prevent the oxidative stress and atherosclerosis \[[@B103-molecules-15-00959]\]. Nevertheless, synergistic effect of lycopene with others antioxidants can be found. Tomato juice fortified with vitamin C gave a higher antioxidant capacity in urine and lower TBARS in plasma and urine \[[@B104-molecules-15-00959]\].

6.2. Cardiovascular disease and related diseases
------------------------------------------------

Cardiovascular disease (CVD) affects the normal function of the cardiovascular system involving heart and blood vessels. The World Health Organization (WHO) \[[@B105-molecules-15-00959]\] reported that CVD is the world's largest killer, claiming 17.1 million lives a year. Tobacco use, unhealthy diet, physical inactivity and high intake of alcohol increase the risk of CVD. Plasma low density lipoprotein (LDL) is the major risk factor of CVD. Increase in LDL oxidation is hypothesized to be causally associated with increasing risk of atherosclerosis and coronary heart disease.

Study has shown that dietary lycopene supplementation (once a day, 1 week each) provided through tomato juice (50.4 mg lycopene), spaghetti sauce (39.2 mg lycopene) and tomato oleoresin (75.0 mg lycopene) will significantly increase serum lycopene \[[@B25-molecules-15-00959]\]. Their study also showed that serum lipid peroxidation and LDL oxidation, significantly decreased after consuming lycopene rich foods, even though no difference was found in serum cholesterol levels. Besides, a high plasma level of lycopene was associated with a decreased risk of CVD in women \[[@B106-molecules-15-00959]\].

The circulating plasma lycopene has been thought to prevent the development of atherosclerosis, especially in smokers \[[@B107-molecules-15-00959]\]. Moreover, Rissanen *et al.* \[[@B108-molecules-15-00959]\] suggested that serum lycopene may play an important role in the early stages of atherosclerosis. It also significantly reduced the formation of atherosclerotic plaques in the aorta and improved lipid profiles in high-fat diet rabbit compared to control group \[[@B109-molecules-15-00959]\]. On the other hand, short term treatment of antioxidant rich tomato extract (250 mg/day, eight weeks) can reduce blood pressure in patients with hypertension \[[@B110-molecules-15-00959]\]. A study by Rissanen *et al.* \[[@B111-molecules-15-00959]\] exhibited an inverse relation between lycopene and intima-media thickness of the carotid artery as the risk factor for CVD.

Nevertheless, there was a study reporting that a high serum level of total carotenes significantly decreased the risk of CVD mortality, but the inverse association between serum lycopene and risk of stroke mortality was not observed \[[@B112-molecules-15-00959]\]. The fact is further supported by Osganian *et al.* \[[@B113-molecules-15-00959]\] that significant inverse association was observed in α-carotene and β-carotene supplementation toward the risk of coronary artery disease, but no significant relation with intake of lycopene. Besides, dietary lycopene was not strongly associated with the decreased risk of CVD. Furthermore, Sesso *et al.* \[[@B114-molecules-15-00959]\] suggested that dietary lycopene may confer preventive benefits on the cardiovascular system, but this possible association is significant for increasing the intake of tomato-based products such as tomato sauce and pizza.

6.3. Cancers
------------

Cancer has emerged as a major public health problem around the world. This health issue has raised the awareness of people to go for natural products and their therapeutic or preventive value. The beneficial effect of lycopene is associated to decrease cancer incidence worldwide especially in prostate. Lycopene (1--4 µM) was also reported to reduce the risk of prostate, lung, leukemic and digestive tract cancers \[[@B115-molecules-15-00959]\]. Besides, research was done on chemopreventive effects of lycopene (10--50 µM) in liver and ovary cells \[[@B89-molecules-15-00959],[@B116-molecules-15-00959]\]. Although, there are chemopreventive effect but the lycopene concentrations used may exceed the normal biological available level.

Study has reported higher plasma lycopene were inversely associated with prostate cancer risk \[[@B117-molecules-15-00959]\]. Lycopene was able to delay high-grade prostate intraepithelial neoplasia (HGPIN) from developing into prostate cancer and also inversely related to the prostate specific antigen \[[@B118-molecules-15-00959]\]. Besides, lycopene (20--60 µM) was able to inhibit the proliferation of prostate cancer cells \[[@B119-molecules-15-00959],[@B120-molecules-15-00959]\]. The antioxidative properties of lycopene was significantly diminished the DNA damage in prostate tissues \[[@B121-molecules-15-00959]\]. Protective effects were also achieved with increase consumption of lycopene-rich diet \[[@B121-molecules-15-00959],[@B122-molecules-15-00959]\]. According to Giovannucci *et al.* \[[@B123-molecules-15-00959]\], frequent intake of tomato or lycopene was associated with lower risk of prostate cancer.

In contrast, some studies showed no beneficial effects of lycopene intake. Kirsh *et al.* \[[@B124-molecules-15-00959]\] reported lycopene, tomatoes or tomato-based foods intake was not associated with prostate cancer risk. Another study prescribed tomato supplement with lycopene (15 mg twice daily) to 46 patients with androgen-independent prostate cancer but the supplementation was not effective \[[@B125-molecules-15-00959]\]. Case-control studies also showed no association between plasma lycopene on prostate cancer risk \[[@B126-molecules-15-00959],[@B127-molecules-15-00959]\]. A synergistic effect of tea and lycopene on prostate cancer risk was also found if increase consumption of green tea with lycopene-rich fruits and vegetables \[[@B128-molecules-15-00959]\]. Thus, it is important in consuming different bioactive compounds for better health instead of a single compound.

On the other hand, lycopene (1--10 µM) was able to inhibit human liver cancerous cells proliferation and preventing them from metastatic process \[[@B129-molecules-15-00959],[@B130-molecules-15-00959]\]. Lycopene has significantly inversed the proliferation of human colon carcinoma, chronic lymphocytic leukemia, erythroleukemia and Burkitt lymphoma cell lines \[[@B115-molecules-15-00959]\]. However, no anti-proliferation effect was found in lycopene treated skin carcinoma, prostate carcinoma, lung carcinoma, and breast carcinoma \[[@B130-molecules-15-00959]\]. Even though, the anti-proliferative effect was dose dependent, Burgess *et al.* \[[@B130-molecules-15-00959]\] mentioned that the effectiveness of lycopene in inhibiting the cancer cell lines needed an extra attention for its physiological achievable level as in human plasma (1--2 µM) and tissues (0.15--21.36 nmol/g tissue) \[[@B6-molecules-15-00959],[@B46-molecules-15-00959]\]. However, the data on highest achievable level of lycopene concentration in human tissues with increasing lycopene intake is unknown. Besides, lycopene did not exhibit any efficiency in inhibiting the progression of preneoplastic oral lesions in hamster buccal pouch \[[@B131-molecules-15-00959]\].

Study has shown that there was no association between some carotenoids and breast cancer among Chinese women, but increased intake of lycopene is associated to a reduced risk of breast cancer \[[@B132-molecules-15-00959]\]. A cohort study concluded that neither high dietary nor plasma lycopene levels were associated with a reduced risk of breast cancer in middle-aged and older women \[[@B133-molecules-15-00959]\]. Besides, no significantassociations were found between lycopene intake and lower risk of gastric cancer \[[@B134-molecules-15-00959]\]. Moreover, apo-10\'-lycopenoic acid (a compound converted from biological metabolite of lycopene) has demonstrated an inhibition effect towards lung cancer and suppression of lung tumor genesis in mice \[[@B135-molecules-15-00959]\]. The beneficial effect of lycopene may be specific for certain organs. In mice study, mutagenesis in mice prostate was slightly inhibited by feeding lycopene-rich tomato oleoresin but mutagenesis was enhanced in the colon and lung \[[@B136-molecules-15-00959]\].

6.4. Diabetes
-------------

Lycopene is closely related to various metabolic complications, especially diabetes. Serum lycopene is inversely associated with type-2 diabetes and impaired glucose metabolism. The fact is proven by Coyne *et al.* \[[@B137-molecules-15-00959]\] that plasma glucose and fasting insulin concentrations decreased significantly with increase in serum lycopene. Besides, Polidori *et al.* \[[@B138-molecules-15-00959]\] found that plasma lycopene were significantly lower in very old diabetic patients as compared to controls, while significant inverse correlations were found between age and lycopene.

In man, dietary lycopene was directly related to baseline serum concentrations of nonesterified fatty acids \[[@B139-molecules-15-00959]\]. Besides that, there is also a concern about dietary lycopene and modulation of insulin-like growth factor (IGF). Riso *et al.* \[[@B140-molecules-15-00959]\] have evaluated the effect of tomato drink intervention providing small amounts of lycopene and other carotenoids on serum levels of IGF-1. The results indicated that lycopene supplementation before and after each experimental period were inversely and significantly correlated with those of IGF-1. However, Wang *et al.* \[[@B141-molecules-15-00959]\] have found low evidence for an association between baseline plasma lycopene and the risk of type-2 diabetes in middle-aged and older women after adjustment for multiple risk factors.

6.5. Other health benefits and safety aspect
--------------------------------------------

Lycopene has its ability to scavenge free radical. Thus lycopene may have health benefit effects and improvement of other disease conditions. Treatment of lycopene (1, 2 and 4 mg/kg; p.o.) in streptozotocin-induced diabetic rats has significantly attenuated cognitive deficit, increased acetylcholinesterase activity, oxidative-nitrosative stress and inflammation \[[@B142-molecules-15-00959]\].

The treatment of lycopene using 3-nitropropionic acid-induced rats has significantly improved the memory and restored glutathione system functioning \[[@B143-molecules-15-00959]\]. Akbaraly *et al.* \[[@B144-molecules-15-00959]\] also suggested that low plasma lycopene levels could contribute to cognitive impairment. The list of lycopene effect on improvement of other disease impairments is shown in [Table 3](#molecules-15-00959-t003){ref-type="table"}.

molecules-15-00959-t003_Table 3

###### 

Action of lycopene in improving the impairment of other diseases.

  Lycopene doses                          Method                                Impairment                                                                      Improvement                                                                                                                         Lit. cited
  --------------------------------------- ------------------------------------- ------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ------------
  0.2 mg/kg b.w. daily                    *In vivo*--rats                       Cataract                                                                        Significant delayed in the onset and progression of galactose cataract and reduced the incidence of selenite cataract.              145
  2.5, 5 and 10 mg/kg b.w. daily          *In vivo*--rats                       Cognitive function                                                              Significant improved in memory.                                                                                                     143
  60 mg/kg b.w. daily                     *In vivo*--hyperlipemia rabbits       Lipid peroxidation injury                                                       Significant reduced in the levels of serum TG and MDA, increase serum SOD activity, increase serum NO.                              146
  0.1, 0.5, 1, 2 g/kg b.w. daily          *In vivo*-- mouse ear oedema model    Swelling                                                                        Decreased swelling of the croton oil-induced ear.                                                                                   147
  0, 5 and 10 μg/mLcarried by liposomes   *In vitro*--Calu-3 cells              Inflammation of cells infected by rhinovirus or exposed to lipopolysaccharide   Reduced the release of interleukin-6 and interferon-gamma induced protein-10.                                                       148
  8 or 16 mg/kg/day by i.p. injection     *In vivo*--murine model of asthma     Ovalbumin-induced inflammation                                                  Significant inhibition of the infiltration of inflammatory immunocytes into the bronchoalveolar lavage.                             149
  2 mgtwice daily                         *In vivo*--primigravida women         Pre-eclampsia and intrauterinegrowth retardation                                Significant reduced in pre-eclamsia incidence and intrauterine growth retardation in the lycopene group compare to placebo group.   150
  9 mg/kg b.w. twice a day for 2 weeks    *In vivo*--rats                       Chronic bacterial prostatitis                                                   Significant decreased in bacterial growth and improvement of prostatic inflammation.                                                151
  0.025--2 mg per 20 mg b.w.              *In vivo*--white heterozygote mouse   X-ray radiation lesions                                                         Moderate curative effect on the radiation lesions and increased survival rate                                                       152

Lycopene supplementation in enucleated rat lenses culture has significantly (*p* \< 0.001) restored glutathione and malondialdehyde levels, superoxide dismutase (*p* \< 0.05), catalase and glutathione *S*-transferase (*p* \< 0.01) \[[@B145-molecules-15-00959]\]. However, no effect was found on glutathione peroxidase in the lycopene-supplemented group. Moreover, serum lycopene concentration was significantly lower in asthmatic \[[@B153-molecules-15-00959]\] and subjects' rheumatoid arthritis \[[@B154-molecules-15-00959]\] than the control group. Dietary supplementation or adequate intake of lycopene and vitamin A rich foods may therefore be beneficial in asthmatic and rheumatoid arthritis.

The safety aspect of bioactive compounds in products has been received much attention from food scientists to avoid any side effects. Either synthetic lycopene or from natural sources have been reported to be safe (Generally Recognized as Safe, GRAS) when used in as food additive \[[@B155-molecules-15-00959]\]. Toxicity studies have demonstrated that usage of synthetic lycopene in rats and rabbits will cause a direct maternal or developmental toxicity at high dosages 2 or 3 g/kg/day \[[@B156-molecules-15-00959]\]. Hence, the safest observed level for lycopene intake is up to 75 mg/day \[[@B157-molecules-15-00959]\]. Thrumbo \[[@B155-molecules-15-00959]\] reviewed no adverse effects were found from animal consumption of dietary or formulated lycopene up to 3g/kg per day. However, only 7--10% of lycopene will be absorbed and 50% of it will be excreted through the feces and urine and the rest remains in the body \[[@B155-molecules-15-00959]\].

7. Lycopene-Rich By-Products from Food Processing
=================================================

Food processing by-products from the tomato puree and sauce industry are commonly used in the development of lycopene-rich products ([Table 4](#molecules-15-00959-t004){ref-type="table"}). Previously, Al-Wandawi *et al.* \[[@B158-molecules-15-00959]\] had reported that tomato skins contained a high amount of lycopene. Food processing waste is commonly used as feed for livestock. Among the agro-industrial by-products (cereal and pulsed, distillery, oil-seeds, sugar industry, textile industry, vegetables and fruits industry, vegetables crop, and miscellancous), tomato wastes are the only by-products that are rich in lycopene \[[@B159-molecules-15-00959]\].

molecules-15-00959-t004_Table 4

###### 

Studies on lycopene from by-products.

  Country              By-products                                       References
  -------------------- ------------------------------------------------- ------------
  Algeria              Tomato skin                                       160
  Argentina            Tomato skin                                       161
  Canada               Tomato skin                                       162
  China, Canada        Tomato paste waste                                163
  China                Tomato paste waste                                164
                       Tomato paste waste                                165
  India                Mace (*Myristica fragrans*)                       166
                       Tomato peels and seeds, tomato industrial waste   167
                       Tomato skin                                       20
  Iraq                 Tomato skin                                       158
  Italy                Tomato peels and seeds                            168
                       Tomato peels                                      169
  Hungary              Tomato pomace                                     19
  Japan                Tomato skin                                       18
  Portugal, Brazil     Tomato skin and seeds                             170
  Spain                Tomato peels                                      171
  Taiwan               Tomato pulp waste                                 172
  Turkey, Netherland   Tomato paste waste                                173
  USA                  Tomato pomace                                     174

Nowadays, there is an increasing trend towards utilization of food processing by-products as a source of functional components \[[@B175-molecules-15-00959]\]. Many studies have been carried out on the extraction of lycopene from by-products especially tomato waste. Optimization of the solvent extraction procedure was also performed to obtain a maximum lycopene yield from tomato peels using response surface methodology \[[@B20-molecules-15-00959]\]. Application of high hydrostatic pressure processing without heating was reported to provide an increased yield of lycopene from tomato paste waste \[[@B165-molecules-15-00959]\]. High pressure processing of tomato paste waste for 1 min gives a higher lycopene yield than solvent extraction for 30 min \[[@B164-molecules-15-00959]\]. The Extractor Naviglio has been introduced to obtain higher purity lycopene from tomato by-products through pressurized extraction \[[@B161-molecules-15-00959],[@B176-molecules-15-00959]\]. This extraction method requires tap water as extracting solvent with minimum organic solvent and the by-products can be further used as livestock feed. Furthermore, enzymatic treatment using cellulase and pectinase could offer one fold higher in the recovery of lycopene from tomato waste \[[@B167-molecules-15-00959]\]. Lavecchia and Zuorro \[[@B169-molecules-15-00959]\] also reported that enzymatic treatment on tomato peels was able to increase the lycopene yield 20-fold. Moreover, supercritical fluid extraction has been applied in extraction of lycopene from several by-products \[[@B17-molecules-15-00959],[@B19-molecules-15-00959],[@B170-molecules-15-00959]\]. Optimization of different extraction parameters on lycopene-rich by-products using supercritical fluid extraction were also studied \[[@B18-molecules-15-00959],[@B162-molecules-15-00959],[@B168-molecules-15-00959],[@B173-molecules-15-00959]\]. Supercritical fluid extract of lycopene-rich tomato pulp waste has been used for encapsulation using an emulsion system in combination with gelatin and poly (γ-glutamic acid) (γ-PGA) as coating materials \[[@B172-molecules-15-00959]\].

On the other hand, there are initiatives by food scientist to recycle the lycopene-rich by-products as food ingredients. Fortification with lycopene in dry fermented sausage was also done by adding dried tomato peel to the meat mixture during the sausage production \[[@B171-molecules-15-00959]\]. The development of extrusion processing using barley-tomato pomace blends and processing into snacks has been demonstrated by Altan *et al.* \[[@B174-molecules-15-00959]\]. Besides, enrichment of low quality edible oils such as refined olive oil, extra virgin olive oil and refined sunflower oil by lycopene from tomato peels or tomato puree was proven to induce thermal stability to these edible oils \[[@B160-molecules-15-00959]\]. The idea of using lycopene-rich by-products from tomato peel and seed for hen feed will further enrich the egg yolk with lycopene. However, only low amounts of lycopene were found to be transferred to the egg yolk (0.1% from tomato peels and 0.7% from tomato seeds) \[[@B177-molecules-15-00959]\]. Another study also determined the quality of lycopene-rich by-products after food processing such as blanching and drying, where blanching in hot water at 75 °C for 2 min could help to reduce the drying time and increase the lycopene bio-availability \[[@B166-molecules-15-00959]\].

8. Thermal Process on Lycopene Content
======================================

Thermal processing is used in the food industry to preserve food products and maintain the nutritional quality. Traditionally, sun drying is the easiest and cheapest technique, and it is commonly used in poor countries or small and medium industries for food preservation. However the disadvantages are food processing enhances lycopene destruction and increases the process duration \[[@B3-molecules-15-00959]\]. The alternative method is oven drying of the food materials. However, lycopene is a heat sensitive compound and degraded when exposed to heat. The temperature is an important factor for thermal processing in order to remove the moisture with minimum destruction of lycopene and other nutrients. Besides, heating of lycopene in oil bath at different times had been shown to enhance the degradation of lycopene when increased in temperature from 50 to 150 °C \[[@B178-molecules-15-00959]\].

Chang *et al.* \[[@B179-molecules-15-00959]\] reported that thermal processing enhanced lycopene isomerization and increased lycopene extracting ability by breaking down the cell walls and weakening the interaction between lycopene and the tissue matrix of samples. Hot air drying at 80 °C for the first 2 h plus shifting the drying temperature to 60 °C for another 6 h were reported to yield higher lycopene content as compared to fresh and freeze dried sample \[[@B179-molecules-15-00959]\]. Besides, treatment of tomatoes with forced air drying at 42 °C for 48 h has shown a significant increase in lycopene contents \[[@B180-molecules-15-00959]\]. In contrast, semi-drying method for drying of tomatoes using a forced air drying at 42 °C for 8 h showed a significant decrease in lycopene content \[[@B181-molecules-15-00959]\].

Lycopene stability is always considered by researchers to ensure that lycopene is able to be preserved until utilization. A study done by Shi *et al.* \[[@B182-molecules-15-00959]\] showed that higher levels of lycopene *cis* isomers, lower total lycopene and *trans* isomers were obtained from tomato using air drying method at 95 °C for 6--10 h as compared to the vacuum drying and osmotic treatment methods. However, lycopene and other lipophilic antioxidant compounds in tomato pulps have high stability after air drying \[[@B183-molecules-15-00959]\].

In air drying processing, total lycopenes was affected by isomerization and oxidation, while there was a significant increase in *cis* isomers and decreased in *trans* isomers when the temperature and processing time increased \[[@B182-molecules-15-00959]\]. Thus, the duration of thermal process also play an important role in lycopene accessibility analysis. Besides, Hsu \[[@B184-molecules-15-00959]\] revealed that hot-break processing (92 °C for 2 min) and cold-break processing (60 °C for 2 min) did not enhance the lycopene extractability and degradation. It was probably due to insufficient temperature and time.

Moisture content is closely related to lycopene degradation. When moisture is retained, the water soluble compounds will react as catalyst during lycopene degradation. Goula *et al.* \[[@B185-molecules-15-00959]\] reported that degradation of lycopene in tomato pulp was reduced when the moisture content decreased from 95% to 55%, with a minimum degradation rate in between 50 to 55% of moisture content. Thus, the catalytic effect of lycopene degradation will eliminated when the moisture is removed.

9. Conclusions
==============

Lycopene is the red pigment that plays an important role in plant and animals. In human health, much evidence shows that consumption of lycopene rich foods can help in preventing degenerative diseases, but very limited studies have found a beneficial role of the consumption of lycopene alone. The interaction of lycopene with other active compounds is crucial for obtaining its optimal function in human health. On the other hand, some beneficial effects may due to the lycopene isomers or its metabolites but information about this is scarce. In addition, further studies on the biological activity of lycopene or with the combination of different compounds are also warranted. Besides, there are only limited studies on long term intake of lycopene that might provide information about the upper limit of lycopene intake. The development of clean technology for high quality nutraceutical products is also needed for the promotion of lycopene consumption. Nonetheless, further understanding of the clinical aspects of lycopene, its mechanism of action towards diseases, bioavailability, bioaccessibility, recommended intake, interaction with other compounds and its metabolites activities are needed due to the lack of conclusive results on the role of lycopene in human health.
